In this review chapter, we provide full comprehensive analysis on the patent, ethics and biosafety regulation with respect to the application of CRISPR technology in mammalian systems. We focused on recent development in CRISPR technology and its patent landscape between countries such as US, European Union, China and Australia. Further, we emphasized on the current scenarios on the ethics regulations with respect to CRISPR research, its applicability in patent and technology transfer. Finally, we elaborated on the biosafety regulation on CRISPR/Cas9 technology application in both mammalian and non-mammalian host system.
Reference:
Nxumalo, P.Z., Takundwa, M. & Thimiri Govinda Raj, D.B. 2021. Patents, ethics, biosafety and regulation using CRISPR technology. Molecular Biology and Translational Science, 181. http://hdl.handle.net/10204/12127
Nxumalo, P. Z., Takundwa, M., & Thimiri Govinda Raj, D. B. (2021). Patents, ethics, biosafety and regulation using CRISPR technology. Molecular Biology and Translational Science, 181, http://hdl.handle.net/10204/12127
Nxumalo, Precious Z, MM Takundwa, and Deepak B Thimiri Govinda Raj "Patents, ethics, biosafety and regulation using CRISPR technology." Molecular Biology and Translational Science, 181 (2021) http://hdl.handle.net/10204/12127
Nxumalo PZ, Takundwa M, Thimiri Govinda Raj DB. Patents, ethics, biosafety and regulation using CRISPR technology. Molecular Biology and Translational Science, 181. 2021; http://hdl.handle.net/10204/12127.
